DING, XIAO,LIU, QIAN,SANG, YINGXIA,STASI, LUIGI PIERO,WAN, ZEHONG,ZHAO, BAOWEI,EDGE, COLIN MICHAEL
申请号：
SG11201605342U
公开号：
SG11201605342UA
申请日:
2015.01.28
申请国别(地区):
SG
年份:
2016
代理人:
摘要：
The present invention relates to novel compounds that inhibit LRRK2 kinase activity, processes for their preparation, to compositions containing them and to their use in the treatment of or prevention of diseases characterized by LRRK2 kinase activity, for example Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis (ALS).
